PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PULMONARY HEART DISEASE”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources
PubMed1992

[Mutual influence of aminophyllin and cefotaxime in the treatment of pulmonary heart disease].

The serum Aminophyllin (TP) and Cefotaxime (CTX) concentration of the patients of pulmonary heart disease during alute attack were measured by HLPC at 2 h and 6 h after infusion. (1) TP and CTX alone were used (2) TP and CTX were used simultaneously. The result showed that the concentrations of TP were much higher, but CTX were much lower when use CTX and TP simultaneously, at 2 h and 6 h (P < 0.01, P < 0.05). The concentration of TP of pulmonary heart disease with heart failure was higher than without heart failure at 6 h when alone were used or simultaneous were used (P < 0.01), CTX wasn't correlated with heart failure. The concentrations of TP and CTX did not correlate with PaO2 and PaCO2. It showed that TP and CTX would not be used simultaneously.

Aminophylline↗
PubMed1996

[The value of the clinical test of glucocorticoid receptors of peripheral blood leukocytes in patients with chronic pulmonary heart disease].

In order to inquire into the functional state of adrenal cortex in patients with pulmonary heart disease, the number of glucocorticoid receptors(GCR) of peripheral blood leukocytes in patients with chronic pulmonary heart disease was determined with radioligand-binding assay and the corresponding plasma cortisol levels were assessed with radioimmune assays. The results showed that the number of GCR in the patients was significantly reduced (P < 0.01) and it was increased when their health state was improved. However, it was still lower than that in healthy subjects (P < 0.01). The number of GCR in the patients was greatly increased when these patients were treated with oxygen (P < 0.01). No difference in plasma cortisol was found between the patients and the healthy subjects (P > 0.05). These results indicate that the function of adrenal cortex may be improved by the compensation mechanism of the patients, but the lower GCR number was the result of lacking of oxygen in the patients. The number of GCR may be improved by inhalation of oxygen. Therefore oxygen therapy is helpful in raising the activity of glucocorticoid receptors and controlling the development of the disease.

Adult↗
PubMed1991

[Tongue picture of blood stasis symptom-complex].

The objective indices of tongue picture of blood stasis symptom-complex in 400 patients with portal hypertension, primary hepatic carcinoma, coronary heart disease, pulmonary heart disease, intermediate and advanced gastric carcinoma were observed during the period of past 6 years. Pale purplish tongue, purplish tongue, bluish purplish tongue, deep-red purplish tongue, dark tongue, yellow purplish tongue etc. were found in these patients. All these were the tongue colour of blood stasis. Ecchymosis, patechiae, streaks, the width of sublingual vein, the appearance of veins and prominences, B mode ultrasonic examination displaying the width of intralingual vein and tissue sound transmission of the tongue body, the blood stasis changes of tongue tip microcirculation, the wave form changes of tongue rheogram had an important significance for diagnosis of blood stasis. There were significant differences in these variables between the subject group and the healthy group or the subject group and the blood non-stasis group statistically (P less than 0.001).

Adult↗
PubMed1990

[Electrocardiogram in pulmonary heart disease--clinical evaluation of right chest leads].

A clinical study was made to evaluate the usefulness of electrocardiograms in right precordial leads (V3r or V4R) for the diagnosis of cardiac complications among patients with chronic pulmonary disease. Walsh and colleagues reported that the change of direction in the terminal vector of QRS loop in the vector cardiogram is useful for the evaluation of chronic pulmonary heart disease. They showed that the terminal vectors of QRS loops tend to deviate to the right and/or posterior direction in the early stage of chronic pulmonary heart disease. We utilized the electrocardiograms in the right precordial leads to detect the second R waves, which are thought to reflect the terminal vectors of QRS loops in the vectorcardiograms. When the electrocardiograms in the right precordial leads were compared, the second R waves in leads V3R or V4R were more frequently observed among patients with chronic pulmonary heart disease than those without. However, in the same two groups, the frequency of second R waves in leads V5R or V6R didn't differ. We conclude that the second R waves in leads V3R or V4R in a patient with chronic lung disease suggest the presence of chronic pulmonary heart disease as a complication.

Adult↗
PubMed2001

[Efficacy of prostaglandin E1 in the treatment of chronic pulmonary heart disease in the elderly people at the acute stage].

OBJECTIVE: To investigate the effects of prostaglandin E1 (PGE1) in the treatment of chronic pulmonary heart disease in the elderlys at the acute stage. METHODS: Forty cases of chronic pulmonary heart disease at the acute stage were treated with PGE1 at the dosage of 100 micrograms.d-1 for 7 days by intravenous drop, other 40 patients with the same disease were treated without PGE1, and 20 healthy subjects were selected as controls. The level of plasma D-dimer and serum fibrin degradation products (FDP), and blood PaO2 and PaCO2 were determined. The patients' symptoms and signs were observed before and after the treatment. RESULTS: The levels of plasma D-dimer and serum FDP were significantly increased (P < 0.01) in both the PGE1 group and the control group (no PGE1) compared to the healthy subjects. In PGE1 and no PGE1 groups the levels of plasma D-dimer and serum FDP were significantly decreased (P < 0.01) after the treatment. The level of PaO2 was increased and there was no significant difference (P > 0.05) between the two groups, but the level of PaCO2 was significantly decreased (P < 0.01) in both PGE1 and no PGE1 groups, but the decreasing in the PGE1 group was lower than that in the no PGE1 group. The symptoms and signs in PGE1 group were more markedly improved than those in the no PGE1 group. CONCLUSIONS: PGE1 is effective in the treatment of chronic pulmonary heart disease in old people at the acute stage.

Aged↗
PubMed1999

[Clinical observation on effect of step respiration exercise combined Chinese drug therapy in treating pulmonary heart disease and exploration on its therapeutic mechanism].

OBJECTIVE: To introduce an auto-electrocardial counterpulsation device, which is non-invasive, nonmedicative and easy to operate, to patients of pulmonary heart disease. And to observe the therapeutic effect of the step respiration exercise (SRE) induced by the device combined with Chinese drug therapy (CDT) on pulmonary heart disease. METHODS: Fifty cases of chronic pulmonary heart disease were divided into SRE group, CDT group and CDT combined SRE group. Blood gas analysis and color ultrasonic Doppler cardiovascular function test were carried out in patients before and after treatment. RESULTS: After 3 courses of treatment, the effect of CDT combined SRE group revealed better than that of the other two groups. CONCLUSIONS: Respiration activity has definite influence on cardiovascular function of patients. SRE can significantly lower the heart rate, reduce the afterload, increase the pressure on coronary orifice by raising arterial diastolic pressure, enhance stroke output and alleviate the work of the heart. CDT can enhance the effect of SRE by synergetically removing pathogens to liberate the Lung, arresting the reversed Qi flow to remove Phlegm and relieve asthma, and replenishing the Kidney to control the reversed Qi.

Aged↗
PubMed1998

[Relationship between plasma NO and PaO2 of artery blood in the patients with chronic pulmonary heart disease].

The plasma nitric oxide(NO) level in the 28 patients with chronic pulmonary heart disease and health controls were measured. The results showed that NO level in the exacerbating patients and stable patients was significantly lower than that in health controls. The NO level in the patients getting worse was markedly lower than that in the stable patients. The lower the oxygen pressure of the artery blood (PaO2), the lower the NO level. when the patient's situation was improving, the plasma NO level increased with rising PaO2. The plasma NO level in patients was associated with the PaO2. This study suggests that the sustained pulmonary hypertension caused by chronic hypoxia may relate to the reduction of NO synthesis and release, and that NO may play an important role in the pathogenesis in chronic pulmonary heart disease.

Aged↗